181 related articles for article (PubMed ID: 10618719)
1. The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-induced transformation.
Nur-E-Kamal MS; Kamal JM; Qureshi MM; Maruta H
Oncogene; 1999 Dec; 18(54):7787-93. PubMed ID: 10618719
[TBL] [Abstract][Full Text] [Related]
2. Requirement of activated Cdc42-associated kinase for survival of v-Ras-transformed mammalian cells.
Nur-E-Kamal A; Zhang A; Keenan SM; Wang XI; Seraj J; Satoh T; Meiners S; Welsh WJ
Mol Cancer Res; 2005 May; 3(5):297-305. PubMed ID: 15886301
[TBL] [Abstract][Full Text] [Related]
3. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
He H; Hirokawa Y; Levitzki A; Maruta H
Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
[TBL] [Abstract][Full Text] [Related]
4. Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation.
He H; Hirokawa Y; Manser E; Lim L; Levitzki A; Maruta H
Cancer J; 2001; 7(3):191-202. PubMed ID: 11419027
[TBL] [Abstract][Full Text] [Related]
5. Influencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42.
Fidyk N; Wang JB; Cerione RA
Biochemistry; 2006 Jun; 45(25):7750-62. PubMed ID: 16784226
[TBL] [Abstract][Full Text] [Related]
6. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
7. Specificity determinants on Cdc42 for binding its effector protein ACK.
Elliot-Smith AE; Mott HR; Lowe PN; Laue ED; Owen D
Biochemistry; 2005 Sep; 44(37):12373-83. PubMed ID: 16156650
[TBL] [Abstract][Full Text] [Related]
8. The gamma-subunit of the coatomer complex binds Cdc42 to mediate transformation.
Wu WJ; Erickson JW; Lin R; Cerione RA
Nature; 2000 Jun; 405(6788):800-4. PubMed ID: 10866202
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
10. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
11. While E1A can facilitate epithelial cell transformation by several dominant oncogenes, the C-terminus seems only to regulate rac and cdc42 function, but in both epithelial and fibroblastic cells.
Fischer RS; Quinlan MP
Virology; 2000 Apr; 269(2):404-19. PubMed ID: 10753719
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
Wang L; Zhu K; Zheng Y
Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
[TBL] [Abstract][Full Text] [Related]
13. Two actions of frabin: direct activation of Cdc42 and indirect activation of Rac.
Ono Y; Nakanishi H; Nishimura M; Kakizaki M; Takahashi K; Miyahara M; Satoh-Horikawa K; Mandai K; Takai Y
Oncogene; 2000 Jun; 19(27):3050-8. PubMed ID: 10871857
[TBL] [Abstract][Full Text] [Related]
14. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
[TBL] [Abstract][Full Text] [Related]
15. An essential role for Rac in Ras transformation.
Qiu RG; Chen J; Kirn D; McCormick F; Symons M
Nature; 1995 Mar; 374(6521):457-9. PubMed ID: 7700355
[TBL] [Abstract][Full Text] [Related]
16. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
17. Cooperation of Cdc42 small G protein-activating and actin filament-binding activities of frabin in microspike formation.
Ikeda W; Nakanishi H; Tanaka Y; Tachibana K; Takai Y
Oncogene; 2001 Jun; 20(27):3457-63. PubMed ID: 11429692
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic and structural analysis of the Drosophila melanogaster p21-activated kinase DmPAK3.
Mentzel B; Raabe T
Gene; 2005 Apr; 349():25-33. PubMed ID: 15777717
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
Yokoyama T
Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
[TBL] [Abstract][Full Text] [Related]
20. trans-Dominant suppressor mutations of the H-ras oncogene.
Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
